TrialSignal
Clinical trial intelligence report
Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT04241211
Status
UNKNOWN
Phase
Phase 4
Sponsor
Seoul National University Bundang Hospital
Executive brief
Investment-Ready Snapshot
This clinical trial investigates the efficacy of Teriparatide (Forsteo) compared to Denosumab (Prolia) in reducing the incidence of Proximal Junctional Kyphosis (PJK) following Adult Spinal Deformity (ASD) surgery. The study is being conducted at Seoul National University Bundang Hospital and aims to provide insights into effective medical therapies for PJK prevention.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04241211
Indication
Spine Deformity
Modality
monoclonal antibody
Target
Proximal Junctional Kyphosis (PJK)
Intervention
Forsteo, Denosumab Prefilled Syringe [Prolia]
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.